We used targeted gene disruption in mice to ablate nonmuscle myosin heavy chain B (NMHC-B), one of the two isoforms of nonmuscle myosin II present in all vertebrate cells. Approximately 65% of the NMHC-B ؊͞؊ embryos died prior to birth, and those that were born suffered from congestive heart failure and died during the first day. 
In vertebrates, most tissues contain two different isoforms of nonmuscle myosin II, II-A and II-B, which are composed of a pair of heavy chains (200 kDa) and two pairs of light chains (20 and 17 kDa) (reviewed in refs. 1 and 2). In humans, the two genes encoding nonmuscle myosin heavy chains (NMHCs) are located on different chromosomes (NMHC-A on 22q11.2 and NMHC-B on 17p13) (3, 4) and, in a variety of species, these genes are expressed in a tissue-specific (5-7) and differentiation-dependent (8-10) manner. Vertebrate neuronal cells are enriched in NMHC-B (7, (10) (11) (12) , whereas splenic tissue and intestinal epithelial cells are enriched in NMHC-A (7, 13) . Nonmuscle myosin II has been shown to play a role in cytokinesis in Dictyostelium (14) , in cell shape changes during Drosophila development (15) , and in determining cell polarity in Caenorhabditis elegans (16) .
The two nonmuscle myosin II isoforms present in vertebrates differ in the rate at which they hydrolyze ATP and propel actin filaments in the in vitro motility assay (17) . While there is some overlap in their intracellular distribution, NMHC-B has been shown to be localized near the plasma membrane of some cells, whereas NMHC-A is found in stress fibers, suggesting that each isoform might have a specific function (12, 17, 18) . However, a number of cells, including rat basophil leukemic cells (19) and human platelets (13, 18) , contain only myosin II-A, whereas a monkey kidney epithelial cell line (COS-7 cells) contains only myosin II-B. Furthermore, cardiac myocytes from newborn mice (8) and primary cultures of embryonic chicken cardiac myocytes were found to contain only NMHC-B and not NMHC-A (20, 21) . Thus, it was of interest to study what effect deletion of the NMHC-B gene product would have upon cardiac development and whether ablation of NMHC-B could be compensated for by NMHC-A in tissues that expressed both isoforms.
MATERIALS AND METHODS
Construction of the Targeting Vector. A 6.5-kb genomic fragment encompassing exon 2 (351 bp) was cloned from a 129͞Sv mouse genomic library (Stratagene). Mutagenesis was performed by digesting the SpeI subclone at a unique BamHI site and inserting a 1.8-kb PGK-Neo transcriptional unit into exon 2, just after the initiating ATG (Fig. 1A) . The final construct contained the neomycin-resistance fragment in the 3Ј-5Ј orientation. The nucleotide sequences at the exon 2-PGK-Neo boundaries were confirmed by restriction mapping and sequencing.
Generation of Transgenic Animals. J1 embryonic stem (ES) cells (a gift of R. Jaenisch) were grown on mouse embryonic fibroblasts treated with mitomycin C. Leukemia inhibitory factor (500 units͞ml) was supplemented in the medium during all passages. A 25-g sample of linearized targeting vector was electroporated into 2 ϫ 10 7 cells, which were plated on gelatin-coated 6-cm plates on neomycin-resistant (Neo r ) embryonic feeder fibroblasts. Selection with G418 was applied 24 h after plating and continued for 7-9 days. Individual Neo r colonies were selected and expanded as described (22) . Genomic DNA was prepared from individual clones and analyzed by Southern blotting using the probe indicated in Fig.  1 A. Five of 341 clones showed evidence for homologous recombination and were used for generation of transgenic mice either by microinjection into embryonic day 3.5 (E3.5) blastocysts or by 8-cell-stage morula aggregation. Chimeric males were scored for germ-line transmission by mating with C57BL͞6J females, followed by Southern blotting (see Fig. 1B ) and PCR analysis of the progeny.
RNA Analysis. Whole brains from newborn ϩ͞ϩ, ϩ͞Ϫ, and Ϫ͞Ϫ mice were used to prepare total RNA by using Trizol reagent (Life Technologies) and analyzed by electrophoresis in
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¶ To whom reprint requests should be addressed at: National Institutes of Health, Building 10, Room 8N202, 10 Center Drive MSC 1762, Bethesda, MD 20892-1762. e-mail: RA19t@nih.gov. a formaldehyde͞1% agarose gel. After transfer to Nytran (Schleicher & Schuell), the blots were analyzed with a mouse cDNA probe specific for NMHC-B and, after being stripped, by a probe specific for the PGK-Neo cassette (see Fig. 1C ). Immunoblot Analysis. Samples for immunoblot analysis were prepared as previously described (13, 17) and transferred to Immobilon P membranes (Millipore) after electrophoresis in SDS͞6% polyacrylamide gels. Proteins were visualized by using Promega Western Blue stabilized substrate for alkaline phosphatase (brain and kidney) as well as Pierce SuperSignal Substrate for Western blotting (heart and lung). The amount of protein loaded was determined by Pierce protein assays and Coomassie blue staining. Blots were analyzed by using polyclonal antibodies specific for NMHC-B and NMHC-A as described (13) .
Histologic and Electron Microscopic Preparations. Fresh tissues were fixed with 10% formalin, embedded in paraffin, sectioned, and stained with hematoxylin and eosin. To evaluate the degree of cardiac hypertrophy, the transverse diameters of the ventricular myocytes were measured in the histologic sections. A high-resolution TV camera and monitor were attached to a light microscope and the magnification was calibrated with a stage micrometer (Zeiss). The transverse diameters of the myocytes were measured (n ϭ 50 for each ventricle) at the levels of the nuclei to the nearest 0.1 m. The mean Ϯ SD was calculated for each individual animal and for each group of animals. The data obtained were analyzed by Student's two-tailed t test. Myocyte disarray was evaluated as absent, mild, moderate, or severe in 20 randomly selected microscopic fields viewed at ϫ100. To evaluate the presence of nonmuscle myosin II-B, paraffin sections of formalin-fixed hearts from E18.5 embryos and newborn ϩ͞ϩ, ϩ͞Ϫ, and Ϫ͞Ϫ mice were immunostained, using the same antibody used for immunoblotting and a goat anti-rabbit IgG conjugated with fluorescein isothiocyanate as the secondary antibody. The sections were then counterstained with propidium iodide to demonstrate nuclei and examined with a confocal microscope. For electron microscopic study, the tissues were fixed with 2.5% glutaraldehyde in 0.1 M sodium phosphate buffer (pH 7.2), postfixed with 1% OsO 4 in 0.1 M phosphate buffer (pH 7.2), and embedded in Polybed 812 (Polysciences). Ultrathin sections were stained with uranyl acetate and lead citrate and examined with a transmission electron microscope.
RESULTS
Targeted Gene Disruption to Eliminate the Myosin II-B Heavy Chain. Fig. 1 A outlines the gene targeting strategy used in these experiments. DNA corresponding to the mouse NMHC-B exon 2 locus was isolated from a genomic DNA library and a replacement-type targeting vector was used to disrupt it as shown. Southern blot analysis of one of the five independent recombinant clones obtained following transfection of ES cells is shown in Fig. 1B (lane 1). These ES cells were used to produce the chimeric males that gave rise to germ-line transmission of the mutant allele, analyses of which are also shown in Fig. 1B (lanes 2-5). This blot was also probed with a neomycin-resistance fragment and the results were consistent with a single recombination event (data not shown). Mice heterozygous (ϩ͞Ϫ) for the NMHC-B mutation were phenotypically indistinguishable from ϩ͞ϩ littermates and were born in the expected Mendelian ratio. However, approximately 65% of the Ϫ͞Ϫ mice died in utero. Those that were born were moribund and, therefore, were sacrificed 1-10 h after birth to obtain undegraded tissue.
Northern blot analysis of ϩ͞ϩ mouse brains revealed the expected mRNA band at 7.5 kb (Fig. 1C ). This figure also demonstrates the appearance of a 9.0-kb message in ϩ͞Ϫ and Ϫ͞Ϫ mice due to the insertion of 1.5 kb of neomycin-resistance mRNA in the NMHC-B transcript. When an NMHC-B probe (Fig. 1C Left) or a neomycin-resistance probe (Fig. 1C Right) was used, the only message detected in Ϫ͞Ϫ mice was at 9.0 kb. Because this message contained a stop codon in all three reading frames, ablation of NMHC-B protein was expected. Fig. 2A is an immunoblot of extracts from newborn kidney, brain, and lung, and newborn and adult hearts. The blot demonstrates that Ϫ͞Ϫ newborn mice lack NMHC-B ( Fig. 2 A Left) and that, with the exception of the heart, all ϩ͞ϩ, ϩ͞Ϫ, and Ϫ͞Ϫ mouse tissues contain NMHC-A (2 A Right). In general, ϩ͞Ϫ mice contained less NMHC-B than did ϩ͞ϩ mice ( Fig. 2 A Left) . As demonstrated in the immunoblot, the ϩ͞ϩ and ϩ͞Ϫ newborn (Fig. 2 A) and embryonic hearts (Fig.  2B) differ from other tissues in that they do not contain NMHC-A. Staining with Coomassie blue confirmed that embryonic mouse hearts, including those from Ϫ͞Ϫ mice, contain ␣ and ␤ cardiac myosin heavy chains (Fig. 2B Left) . In contrast to newborn and embryonic mouse hearts, NMHC-B (and NMHC-A) are absent from ϩ͞ϩ and ϩ͞Ϫ adult mouse hearts (Fig. 2 A) . However, careful inspection of the anti-NMHC-A blot of the Ϫ͞Ϫ newborn heart occasionally revealed a signal for NMHC-A. We, therefore, undertook a study of NMHC-A and NMHC-B protein in the hearts of embryonic mice as detected by immunoblot analyses. purple, congested liver, easily seen through the skin, and an abnormal, dome-shaped head. Fig. 3 B and C show intact hearts from a ϩ͞ϩ (B) and a Ϫ͞Ϫ (C) newborn mouse. The Ϫ͞Ϫ heart has an abnormal, rounded shape (see Fig. 3  legend) . (Fig. 5B) . The latter corresponded to accumulations of glycogen particles, as confirmed by specific staining (data not shown). The occurrence of cardiac hypertrophy in the newborn Ϫ͞Ϫ mice was documented by the quantitative measurements of myocyte diameters (see Table 1 ). The table also shows that cardiac myocyte hypertrophy was present as early as E12.5 and thus preceded the development of the VSD and overriding of the aorta. Immunostaining demonstrated the presence of NMHC-B in the hearts of E18.5 ϩ͞Ϫ (not shown) and ϩ͞ϩ mice, as well as the absence of this protein in the hearts of Ϫ͞Ϫ embryos (Fig. 5 C and D) .
Electron microscopic examination of the hearts of newborn Ϫ͞Ϫ mice confirmed the findings of hypertrophy of the ventricular myocytes and disclosed focal disarray of the myofilaments (Fig. 5 E and F) ; however, the structure of the various components of the sarcomeres, the intercellular junctions, the sarcoplasmic reticulum, and the mitochondria appeared normal. The right atrial myocytes of Ϫ͞Ϫ mice were also enlarged and contained more numerous cisterns of endoplasmic reticulum and Golgi complexes, as well as more abundant glycogen particles, than did normal controls (data not shown). The endocardial and capillary endothelial cells appeared normal, as did the smooth muscle cells of the great vessels and the cardiac interstitial fibroblasts. Numbers in parentheses are number of mice examined. RV, right ventricle; LV, left ventricle. ‫,ء‬ P Ͻ 0.001; †, P Ͻ 0.01. Examination of all other organs of newborn Ϫ͞Ϫ mice revealed primary abnormalities only in the brain and retina (see Discussion). Evidence for tissue changes secondary to congestive heart failure were seen in the liver, kidney, and spleen, but, unlike the findings in the heart, no primary cellular abnormalities were seen.
DISCUSSION
Cardiac failure was thought to be the cause of death in the NMHC-B Ϫ͞Ϫ mice. This failure appeared to be a consequence of the cardiac hypertrophy and the cardiac malformations. The moderate myofibrillar disarray could also contribute to the severity of the failure, as has been noted previously (23) . Two other abnormalities were observed in these mice, retinal dysplasia with rosette formation, indicating a failure in the development of the bipolar layer of the retinal ganglion cells (not shown) and hydrocephalus, which involved the lateral ventricles of the brain and resulted in a dome-shaped skull (see Fig. 3 ). All of the other organs showed no evidence of any primary abnormalities. Because these organs are known to express both myosin isoforms (see Fig. 2 ), the most logical explanation is that NMHC-A can compensate for NMHC-B during embryonic development of these tissues. This does not appear to be true for the cardiac myocytes. In contrast to these cells, cardiac fibroblasts showed no obvious abnormalities in number or ultrastructural morphology.
The most striking structural defects in the hearts of Ϫ͞Ϫ mice are the VSD and cardiac outflow tract abnormalities. Despite their relative frequency among congenital heart de- fects, the pathogenesis of these cardiac defects remains unclear. In the chick, a number of manipulations have been shown to interfere with the processes of convergence and wedging of the cardiac inflow and outflow tracts, which determine the final relative positions of the ventricular outflow tracts and the great vessels. These manipulations include venous or arterial occlusion and partial ablation of the cardiac neural crest (for a review, see ref. 24) . The mechanism for the misalignment is unknown. A possible cause for the structural defects observed in these mice is that the myocyte hypertrophy in the Ϫ͞Ϫ embryos causes an abnormal feedback to the developing myocardium, which in turn is unable to complete the cardiac looping process normally. The normal septation between the aorta and the pulmonary artery argues against the presence of a primary defect in the neural crest cells (24) .
In mice, the occurrence of a VSD and abnormalities of the great vessels has been reported after targeted disruption of a number of genes, including NF1 (VSD; disoriented, poorly developed myocytes; ref. 25 (20, 21) and one on embryonic, newborn, and adult mouse hearts (8) , reported that cardiac myocytes contained NMHC-B, but not NMHC-A. Although our results do not confirm the previously postulated role for NMHC-B in myofibrillogenesis (20) , because the hypertrophied cardiac myocytes do contain well developed myofibrils (Fig. 5) , they do suggest that cardiac myocytes require NMHC-B for normal development. Because mild to moderate myofibrillar disarray is seen in the Ϫ͞Ϫ mouse heart (see Fig. 5F ), we cannot rule out a defect in myofibrillar structure subsequent to the assembly of filaments. In addition, we cannot rule out a contribution by the nonmuscle cells, such as fibroblasts, that are present in the developing heart.
At present, the cause of the hypertrophy of the cardiac myocytes in NMHC-B Ϫ͞Ϫ mice is unknown. The finding that the abnormal transverse diameters were similar in the left and right ventricular myocytes of newborn Ϫ͞Ϫ mice (see Table 1 ), as well as their presence in both atria (data not shown), suggests that a generalized cellular defect contributed to the pathogenesis of this hypertrophy. In addition, the timing of the hypertrophy is unusual in that it was seen as early as E12.5-i.e., at a time when cardiac myocytes are still capable of undergoing cytokinesis and would be expected to undergo hyperplasia rather than hypertrophy. Thus, normal embryonic and newborn cardiac myocytes, which contain NMHC-B, can undergo cytokinesis, but this ceases soon after birth. The hypertrophic response of the NMHC-B Ϫ͞Ϫ embryonic and newborn cardiac myocytes is reminiscent of the abnormal enlargement of cells found in Dictyostelium discoideum that were rendered null for the single isoform of nonmuscle myosin II (14) . These cells were defective in cytokinesis but underwent karyokinesis and became enlarged and multinucleated. The hypertrophied myocytes in Ϫ͞Ϫ mice, however, clearly were capable of dividing and were not multinucleated. Thus, any defect in cytokinesis must have been compensated for, albeit incompletely, by other proteins. Four of eight NMHC-B Ϫ͞Ϫ mice showed evidence for up-regulation of NMHC-A protein in the heart during embryogenesis. The variation in this expression may be due, in part, to the mixed genetic background of the mice under study. We also cannot exclude the possibility that small amounts of NMHC-A, below the limits of detection, are present in the cardiac myocytes of NMHC-B Ϫ͞Ϫ mice, which could suffice for cytokinesis, but not for rescue of the phenotype.
Congenital heart defects in humans are present in nearly 1% of all newborns and continue to be a significant cause of death in infancy (28) . Of particular interest is the possible relevance of the cardiac abnormalities in the NMHC-B Ϫ͞Ϫ mice to human diseases such as tetralogy of Fallot and double outlet right ventricle. Both of these disorders involve the cardiac outflow tract. In the former, the aorta straddles the left and right ventricle, whereas in the latter it originates entirely from the right ventricle. However, intermediate forms are known to exist (29) . Our present studies, which are directed toward understanding the function of NMHC-B in the pathogenesis of these defects, should aid in elucidating this connection.
